Published: Wed, June 13, 2018
Health Care | By Cedric Leonard

KKR To Acquire Envision's Common Stock For $46.00/shr

KKR To Acquire Envision's Common Stock For $46.00/shr

Shares of Envision Healthcare opened at $43.64 on Friday, reports. Envision Healthcare reported sales of $1.95 billion during the same quarter last year, which indicates a positive year over year growth rate of 7.7%.

Several brokerages recently issued reports on EVHC. Envision Healthcare had 24 analyst reports since December 13, 2017 according to SRatingsIntel. The transaction may undervalue the Company and may not be in the Envision Healthcare shareholders best interests. Zacks' sales averages are a mean average based on a survey of sell-side research firms that cover Envision Healthcare. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned "Hold" rating by Piper Jaffray on Wednesday, February 28. Envision Healthcare had a return on equity of 8.05% and a net margin of 6.06%. The company had revenue of $2.08 billion for the quarter, compared to the consensus estimate of $2.02 billion. During the same period in the previous year, the company posted $0.77 EPS. The company's revenue for the quarter was up 10.6% on a year-over-year basis.

A number of research analysts have commented on the company. Zacks Investment Research raised shares of Envision Healthcare from a "hold" rating to a "buy" rating and set a $46.00 price objective on the stock in a report on Friday, May 11th.

Ireland: Polish man Mikolaj Wilk murdered in home invasion, partner seriously injured
Wilk , also known as Nick, ran a garden maintenance business in the area and had lived in Ireland for a number of years. The couple were rushed to Cork University Hospital for treatment, however Mr Wilk was pronounced dead at around 5.30am.

KKR itself said last month it would buy business software company BMC Software, in a deal that could be worth about US$8.5 billion with debt, according to Reuters' sources. On Wednesday, February 28 the stock rating was maintained by Cantor Fitzgerald with "Neutral". One analyst has rated the stock with a sell rating, two have given a hold rating, ten have given a buy rating and one has assigned a strong buy rating to the stock. The stock presently has a consensus rating of "Hold" and an average target price of $41.10. Federated Investors Inc. PA now owns 2,753 shares of the company's stock valued at $106,000 after buying an additional 1,819 shares during the period. Finally, Alps Advisors Inc. acquired a new position in shares of Envision Healthcare in the fourth quarter valued at approximately $235,000. Mackay Shields LLC bought a new position in shares of Envision Healthcare during the 1st quarter worth about $783,000. Boston Partners grew its stake in Envision Healthcare by 362.0% in the 1st quarter. State Treasurer State of MI now owns 38,600 shares of the company's stock valued at $2,367,000 after buying an additional 200 shares in the last quarter. Finally, SG Americas Securities LLC lifted its position in shares of Envision Healthcare by 334.4% during the 4th quarter. (NYSE:EVHC) by 23.5% during the first quarter, Holdings Channel reports. The company has a debt-to-equity ratio of 0.65, a current ratio of 2.27 and a quick ratio of 2.25. For example, shares of Envision Healthcare stock have traded at $134.13 per share and an analyst has set a $51.00 per share price target for the stock.

Envision Healthcare Corporation (NYSE:EVHC) has declined 22.24% since June 12, 2017 and is downtrending. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR).

Like this: